Suchergebnisse - "Kim, Yong-Mi"

PubPharm (100)

1

Targeting integrins in drug-resistant acute myeloid leukaemia

enthalten in: British journal of pharmacology | 2024

von Ogana, H. | Hurwitz, S. | Wei, N. | +4

2

Targeting integrins in drug‐resistant acute myeloid leukaemia

enthalten in: British Journal of Pharmacology | 2024

von Ogana, H. | Hurwitz, S. | Wei, N. | +4

3

A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid Deleterious ROS by Suppressing Mitochondrial Complex I

enthalten in: Current molecular pharmacology | 2024

von Chimge, N. | Chen, M. | Nguyen, C. | +13

4

Oligo antisentido para su uso en el tratamiento de la leucemia mieloide aguda

enthalten in: Europäisches Patentamt | 2023

von TACHAS GEORGE | KIM YONG-MI

5

Altered physical phenotypes of leukemia cells that survive chemotherapy treatment

enthalten in: Integrative biology : quantitative biosciences from nano to macro | 2023

von Ly, C. | Ogana, H. | Kim, H. | +4

6

Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia

enthalten in: Frontiers in cell and developmental biology | 2023

von Ogana, H. | Hurwitz, S. | Hsieh, C. | +7

7

Editorial : New immunotherapeutic and pharmacological targets and strategies in haematological malignancies

enthalten in: Frontiers in pharmacology | 2023

von Williams, M. | Kim, Y. | Guzman, M.

8

Editorial : Women in pediatric oncology Vol II: 2022

enthalten in: Frontiers in oncology | 2023

von Kim, Y. | Kitlinska, J.

9

Editorial : Microenvironment and therapy-resistance in leukemias

enthalten in: Frontiers in oncology | 2023

von Friedmann, R. | Kim, Y. | Konopleva, M.

10

REPROGRAMMING CBX8-PRC1 FUNCTION WITH A POSITIVE ALLOSTERIC MODULATOR

enthalten in: bioRxiv.org | 2022

von Suh, J. | Bsteh, D. | Si, Y. | +24

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]